Jennifer (Yujia) Jiang
Lawyers
Counsel in our Corporate practice, currently practicing as a Registered Foreign Lawyer in Hong Kong.
Experience
- HighTide Therapeutics HK$194.1 million Hong Kong IPO and global offering
- WuXi XDC HK$3.68 billion Hong Kong IPO and global offering
- MedSci Healthcare HK$608 million Hong Kong IPO and global offering
- Interra Acquisition HK$1 billion Hong Kong SPAC IPO
- CANbridge Pharmaceuticals’$87.9 million Hong Kong IPO and global offering
- ANE’s $143 million Hong Kong IPO and global offering
- Abbisko’s $225 million Hong Kong IPO and global offering
- Broncus’ $215 million Hong Kong IPO and global offering
- Black Spade Acquisition Co.’s $150 million U.S. IPO on the NYSE
- Baidu’s $3.1 billion Hong Kong secondary listing
- Antengene’s $357 million Hong Kong IPO and global offering
- RemeGen’s $514.3 million Hong Kong IPO and global offering
- InnoCare Pharma’s $287 million Hong Kong IPO and global offering
- LIZHI INC’s $45.1 million SEC-registered IPO on Nasdaq
- DouYu’s $775 million SEC-registered U.S. IPO on Nasdaq
- CStone Pharmaceuticals’ $285 million Hong Kong IPO and global offering
- CNFinance’s $51.94 million SEC-registered U.S. IPO on the NYSE
- Black Spade Acquisition $23 billion combination with VinFast
- Sea Limited multiple convertible notes offerings
- Temasek €1.5 billion guaranteed notes offering
- PT Freeport Indonesia $3 billion notes offering
- Bangkok Bank $750 million Tier 1 subordinated perpetual notes offering
- DuPont Fabros Technology, Inc. $200 million SEC-registered at-the-market offering
- Johnson Controls International plc $500 million senior notes offering
Education
J.D., Northwestern University Pritzker School of Law
LL.M., Cornell Law School
LL.B., Civil, Commercial and Economic Law School, China University of Political Science and Law
Qualifications and admissions
- Hong Kong Law Society - Registered
- State of New York